← Back to Search

Mobile Tech System for Heart Failure Management

N/A

Waitlist Available

Led By Alex Sandhu, MD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥ 18

Diagnosis of heart failure

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 6 week, at study completion (12-week follow-up visit)

Awards & highlights

Study Summary

This trial uses tech to help manage heart failure and check its effectiveness.

Who is the study for?

This trial is for adults over 18 with heart failure, recently hospitalized or discharged, and have a left ventricular ejection fraction of ≤40%. They must be starting or on low doses of certain heart medications and have a smartphone. Excluded are those listed for heart transplants, in other studies, without English proficiency, with life-threatening conditions or expected short lifespan.Check my eligibility

What is being tested?

The study tests a digital system combining healthcare provider desktop/mobile apps with patient mobile apps to manage heart failure. It aims to evaluate the system's practicality and how well patients and doctors accept and use it.See study design

What are the potential side effects?

Since this trial involves using technology rather than medication, there aren't typical drug side effects. However, participants may experience issues related to app usability or stress from managing their condition through the technology.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have been diagnosed with heart failure.

Select...

I was recently in the hospital and have been or will be discharged within the last 2 weeks.

Select...

I am on less than half the dose or haven't started at least two recommended heart failure treatments.

Select...

My heart's pumping ability is reduced (≤ 40% efficiency).

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 6 week, at study completion (12-week follow-up visit)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 6 week, at study completion (12-week follow-up visit)

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 6 week, at study completion (12-week follow-up visit) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Clinicians' Response to Notification

Patient Acceptability of the intervention

Patients' Engagement score

Secondary outcome measures

Acceptability of DOT-HF technology for Clinicians

Feasibility of DOT-HF technology for Patients

Generalizability of the DOT-HF Intervention

+8 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Digital technology-based system for heart failure managementExperimental Treatment1 Intervention

This is a single-arm study to assess the feasibility and preliminary effectiveness of a digital technology-based system for heart failure management

0 / 5Eligibility criteria met

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,387 Previous Clinical Trials

17,334,020 Total Patients Enrolled

18 Trials studying Heart Failure

56,328 Patients Enrolled for Heart Failure

Alex Sandhu, MDPrincipal InvestigatorStanford University

Media Library

Digital technology-based system for heart failure management Clinical Trial Eligibility Overview. Trial Name: NCT05647317 — N/A

Heart Failure Research Study Groups: Digital technology-based system for heart failure management

Heart Failure Clinical Trial 2023: Digital technology-based system for heart failure management Highlights & Side Effects. Trial Name: NCT05647317 — N/A

Digital technology-based system for heart failure management 2023 Treatment Timeline for Medical Study. Trial Name: NCT05647317 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Have enrollment opportunities opened up for this experiment?

"As of now, prospective participants are not being accepted for this trial; the original post was on July 28th 2023 with a recent update taking place four days prior. However, there are 739 other studies actively seeking enrolment across various locations."

Answered by AI

What aim is this trial seeking to accomplish?

"The primary aim of this clinical trial, assessed upon completion (12-week follow up visit), is to gauge Patients' Engagement scores. As secondary outcomes, researchers will be measuring the Proportion of days with weight assessment, Proportion of days with daily health status completed and the Proportion of Kansas City Cardiomyopathy Questionnaire-12 assessments completed; all these metrics are bounded between 0% to 100%."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Mobile Technology-Based System for Patient Engagement and Physician-Directed Remote Management of Heart Failure

Alexander Sandhu 2023. "Mobile Technology-Based System for Patient Engagement and Physician-Directed Remote Management of Heart Failure". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05647317.